|
1
|
Cancer Genome Atlas Research Network.
Comprehensive molecular characterization of urothelial bladder
carcinoma. Nature. 507:315–322. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Figueroa JD, Malats N, García-Closas M,
Real FX, Silverman D, Kogevinas M, Chanoc S, Welch R, Dosemeci M,
Lan Q, et al: Bladder cancer risk and genetic variation in AKR1C3
and other metabolizing genes. Carcinogenesis. 29:1955–1962.
2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Schulster M: Bladder cancer academy 2019
selected summaries. Rev Urol. 21:23–28. 2019.PubMed/NCBI
|
|
4
|
Vlachostergios PJ and Faltas BM: The
molecular limitations of biomarker research in bladder cancer.
World J Urol. 37:837–848. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Dong D, Ako R and Wu B: Crystal structures
of human sulfotransferases: Insights into the mechanisms of action
and substrate selectivity. Expert Opin Drug Metab Toxicol.
8:635–646. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kauffman FC: Conjugation-deconjugation
reactions in drug metabolism and toxicity. Fed Proc. 46:2434–2445.
1987.PubMed/NCBI
|
|
7
|
Cole P, Monson RR, Haning H and Friedell
GH: Smoking and cancer of the lower urinary tract. N Engl J Med.
284:129–134. 1971.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Cole P, Hoover R and Friedell GH:
Occupation and cancer of the lower urinary tract. Cancer.
29:1250–1260. 1972.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Sabbioni G, Jones CR, Sepai O, Hirvonen A,
Norppa H, Järventaus H, Glatt H, Pomplun D, Yan H, Brooks LR, et
al: Biomarkers of exposure, effect, and susceptibility in workers
exposed to nitrotoluenes. Cancer Epidemiol Biomarkers Prev.
15:559–566. 2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Arlt VM, Stiborova M, Henderson CJ,
Osborne MR, Bieler CA, Frei E, Martinek V, Sopko B, Wolf CR,
Schmeiser HH and Phillips DH: Environmental pollutant and potent
mutagen 3-nitrobenzanthrone forms DNA adducts after reduction by
NAD(P)H:quinone oxidoreductase and conjugation by
acetyltransferases and sulfotransferases in human hepatic cytosols.
Cancer Res. 65:2644–2652. 2005.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sidorenko VS, Attaluri S, Zaitseva I, Iden
CR, Dickman KG, Johnson F and Grollman AP: Bioactivation of the
human carcinogen aristolochic acid. Carcinogenesis. 35:1814–1822.
2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Nowell S, Green B, Tang YM, Wiese R and
Kadlubar FF: Examination of human tissue cytosols for expression of
sulfotransferase isoform 1A2 (SULT1A2) using a SULT1A2-specific
antibody. Mol Pharmacol. 67:394–399. 2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Svendsen C, Meinl W, Glatt H, Alexander J,
Knutsen HK, Hjertholm H, Rasmussen T and Husøy T: Intestinal
carcinogenesis of two food processing contaminants,
2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and
5-hydroxymethylfurfural, in transgenic FVB min mice expressing
human sulfotransferases. Mol Carcinog. 51:984–992. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Sanli O, Dobruch J, Knowles MA, Burger M,
Alemozaffar M, Nielsen ME and Lotan Y: Bladder cancer. Nat Rev Dis
Primers. 3(17022)2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Situ DR, Hu Y, Zhu ZH, Wang J, Long H and
Rong TH: Prognostic relevance of β-catenin expression in T2-3N0M0
esophageal squamous cell carcinoma. World J Gastroenterol.
16:5195–5202. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Regier N and Frey B: Experimental
comparison of relative RT-qPCR quantification approaches for gene
expression studies in poplar. BMC Mol Biol. 11(57)2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Song Y, Jin D, Ou N, Luo Z, Chen G, Chen
J, Yang Y and Liu X: Gene expression profiles identified novel
urine biomarkers for diagnosis and prognosis of high-grade bladder
urothelial carcinoma. Front Oncol. 10(394)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Huang YD, Shan W, Zeng L and Wu Y:
Screening of differentially expressed genes related to bladder
cancer and functional analysis with DNA microarray. Asian Pac J
Cancer Prev. 14:4553–4557. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Heidegger I, Borena W and Pichler R: The
role of human papilloma virus in urological malignancies.
Anticancer Res. 35:2513–2519. 2015.PubMed/NCBI
|
|
20
|
Kachrilas S, Dellis A, Papatsoris A,
Avgeris S, Anastasiou D, Gavriil A, Horti M, Tseleni Balafouta S,
Livadas K, Stravopodis DJ, et al: PI3K/AKT pathway genetic
alterations and dysregulation of expression in bladder cancer. J
BUON. 24:329–337. 2019.PubMed/NCBI
|
|
21
|
Liu J, Li H, Shen S, Sun L, Yuan Y and
Xing C: Alternative splicing events implicated in carcinogenesis
and prognosis of colorectal cancer. J Cancer. 9:1754–1764.
2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Peng CT, Chen JC, Yeh KT, Wang YF, Hou MF,
Lee TP, Shih MC, Chang JY and Chang JG: The relationship among the
polymorphisms of SULT1A1, 1A2 and different types of cancers in
Taiwanese. Int J Mol Med. 11:85–89. 2003.PubMed/NCBI
|
|
23
|
McGowan PM, Kirstein JM and Chambers AF:
Micrometastatic disease and metastatic outgrowth: Clinical issues
and experimental approaches. Future Oncol. 5:1083–1098.
2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ahmad A, Wang Z, Kong D, Ali S, Li Y,
Banerjee S, Ali R and Sarkar FH: FoxM1 down-regulation leads to
inhibition of proliferation, migration and invasion of breast
cancer cells through the modulation of extra-cellular matrix
degrading factors. Breast Cancer Res Treat. 122:337–346.
2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Liguori M, Solinas G, Germano G, Mantovani
A and Allavena P: Tumor-associated macrophages as incessant
builders and destroyers of the cancer stroma. Cancers (Basel).
3:3740–3761. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kassouf W, Dinney CP, Brown G, McConkey
DJ, Diehl AJ, Bar-Eli M and Adam L: Uncoupling between epidermal
growth factor receptor and downstream signals defines resistance to
the antiproliferative effect of Gefitinib in bladder cancer cells.
Cancer Res. 65:10524–10535. 2005.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kumar B, Koul S, Petersen J, Khandrika L,
Hwa JS, Meacham RB, Wilson S and Koul HK: p38 mitogen-activated
protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer
by modulation of MMP-2 and MMP-9 activity. Cancer Res. 70:832–841.
2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhao L, Zhang T, Geng H, Liu ZQ, Liang ZF,
Zhang ZQ, Min J, Yu DX and Zhong CY: MAPK/AP-1 pathway regulates
benzidine-induced cell proliferation through the control of cell
cycle in human normal bladder epithelial cells. Oncol Lett.
16:4628–4634. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sun X, Zhang T, Deng Q, Zhou Q, Sun X, Li
E, Yu D and Zhong C: Benzidine induces epithelial-mesenchymal
transition of human bladder cancer cells through activation of ERK5
pathway. Mol Cells. 41:188–197. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Houédé N and Pourquier P: Targeting the
genetic alterations of the PI3K-AKT-mTOR pathway: Its potential use
in the treatment of bladder cancers. Pharmacol Ther. 145:1–18.
2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Khadjavi A, Mannu F, Destefanis P,
Sacerdote C, Battaglia A, Allasia M, Fontana D, Frea B, Polidoro S,
Fiorito G, et al: Early diagnosis of bladder cancer through the
detection of urinary tyrosine-phosphorylated proteins. Br J Cancer.
113:469–475. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Douglawi A and Masterson TA: Updates on
the epidemiology and risk factors for penile cancer. Transl Androl
Urol. 6:785–790. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Berrada N, Al-Bouzidi A, Ameur A, Abbar M,
El-Mzibri M, Ameziane-El-Hassani R, Benbacer L, Khyatti M, Qmichou
Z, Amzazi S and Attaleb M: Human papillomavirus detection in
Moroccan patients with bladder cancer. J Infect Dev Ctries.
7:586–592. 2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Alexander RE, Hu Y, Kum JB, Montironi R,
Lopez-Beltran A, Maclennan GT, Idrees MT, Emerson RE, Ulbright TM,
Grignon DG, et al: p16 expression is not associated with human
papillomavirus in urinary bladder squamous cell carcinoma. Mod
Pathol. 25:1526–1533. 2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Polesel J, Gheit T, Talamini T, Shahzad N,
Lenardon O, Sylla B, La Vecchia C, Serraino D, Tommasino M and
Franceschi S: Urinary human polyomavirus and papillomavirus
infection and bladder cancer risk. Br J Cancer. 106:222–226.
2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Weinstein SJ, Ziegler RG, Selhub J, Fears
TR, Strickler HD, Brinton LA, Hamman RF, Levine RS, Mallin K and
Stolley PD: Elevated serum homocysteine levels and increased risk
of invasive cervical cancer in US women. Cancer Causes Control.
12:317–324. 2001.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Moonen PM, Bakkers JM, Kiemeney LA,
Schalken JA, Melchers WJ and Witjes JA: Human papilloma virus DNA
and p53 mutation analysis on bladder washes in relation to clinical
outcome of bladder cancer. Eur Urol. 52:464–468. 2007.PubMed/NCBI View Article : Google Scholar
|
